List of City of Hope patents

Patents where

Current Assignee

Name

City of Hope

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7446179 CD19-specific chimeric T cell receptor	Patent 7446179 was granted and assigned to City of Hope on November, 2008 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7446179	November 4, 2008
‌ US Patent 7446191 DNA construct encoding CE7-specific chimeric T cell receptor	Patent 7446191 was granted and assigned to City of Hope on November, 2008 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7446191	November 4, 2008
‌ US Patent 7265209 CE7-specific chimeric T cell receptor	Patent 7265209 was granted and assigned to City of Hope on September, 2007 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7265209	September 4, 2007
‌ US Patent 7514537 Chimeric immunoreceptor useful in treating human gliomas	Patent 7514537 was granted and assigned to City of Hope on April, 2009 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7514537	April 7, 2009
‌ US Patent 7070995 CE7-specific redirected immune cells	Patent 7070995 was granted and assigned to City of Hope on July, 2006 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7070995	July 4, 2006
‌ US Patent 7105298 Serial coupling of restriction cleavage and extension for nucleic acid amplification	Patent 7105298 was granted and assigned to City of Hope on September, 2006 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7105298	September 12, 2006
‌ US Patent 9657105 CD123-specific chimeric antigen receptor redirected T cells and methods of their use	Patent 9657105 was granted and assigned to City of Hope on May, 2017 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	9657105	May 23, 2017
‌ US Patent 7354762 Method for producing CE7-specific redirected immune cells	Patent 7354762 was granted and assigned to City of Hope on April, 2008 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7354762	April 8, 2008
‌ US Patent 7504221 Pyrophosphorolysis activated polymerization (PAP)	Patent 7504221 was granted and assigned to City of Hope on March, 2009 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7504221	March 17, 2009
‌ US Patent 7238480 Pyrophosphorolysis activated polymerization (PAP)	Patent 7238480 was granted and assigned to City of Hope on July, 2007 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7238480	July 3, 2007
‌ US Patent 9512076 Indirubin derivatives and uses thereof in treating chronic myelogenous leukemia	Patent 9512076 was granted and assigned to City of Hope on December, 2016 by the United States Patent and Trademark Office.	City of Hope	City of Hope	United States Patent and Trademark Office	9512076	December 6, 2016
‌ US Patent 9580685 Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection	Patent 9580685 was granted and assigned to City of Hope on February, 2017 by the United States Patent and Trademark Office.	City of Hope	City of Hope	United States Patent and Trademark Office	9580685	February 28, 2017
‌ US Patent 8927514 Recombinant adeno-associated vectors for targeted treatment	Patent 8927514 was granted and assigned to City of Hope on January, 2015 by the United States Patent and Trademark Office.	City of Hope	City of Hope	United States Patent and Trademark Office	8927514	January 6, 2015
‌ US Patent 7390298 Expandable surgical retractor for internal body spaces approached with minimally invasive incisions or through existing orifices	Patent 7390298 was granted and assigned to City of Hope on June, 2008 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7390298	June 24, 2008
‌ US Patent 7141153 pK-matched running buffers for gel electrophoresis	Patent 7141153 was granted and assigned to City of Hope on November, 2006 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7141153	November 28, 2006
‌ US Patent 9623120 Recombinant adeno-associated vectors for targeted treatment	Patent 9623120 was granted and assigned to City of Hope on April, 2017 by the United States Patent and Trademark Office.	City of Hope	City of Hope	United States Patent and Trademark Office	9623120	April 18, 2017
‌ US Patent 11604185 Methods for detection of botulinum neurotoxin	Patent 11604185 was granted and assigned to City of Hope on March, 2023 by the United States Patent and Trademark Office.	City of Hope	City of Hope	United States Patent and Trademark Office	11604185	March 14, 2023
‌ US Patent 9931395 MVA vaccine for delivery of a UL128 complex and preventing CMV infection	Patent 9931395 was granted and assigned to City of Hope on April, 2018 by the United States Patent and Trademark Office.	City of Hope	City of Hope	United States Patent and Trademark Office	9931395	April 3, 2018
‌ US Patent 7256037 Modified vaccinia Ankara expressing p53 in cancer immunotherapy	Patent 7256037 was granted and assigned to City of Hope on August, 2007 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7256037	August 14, 2007
‌ US Patent 10100281 Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection	Patent 10100281 was granted and assigned to City of Hope on October, 2018 by the United States Patent and Trademark Office.	City of Hope	City of Hope	United States Patent and Trademark Office	10100281	October 16, 2018
‌ US Patent 7563448 Modified vaccinia ankara expressing P53 in cancer immunotherapy	Patent 7563448 was granted and assigned to City of Hope on July, 2009 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7563448	July 21, 2009
‌ US Patent 11155783 Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection	Patent 11155783 was granted and assigned to City of Hope on October, 2021 by the United States Patent and Trademark Office.	City of Hope	City of Hope	United States Patent and Trademark Office	11155783	October 26, 2021
‌ US Patent 10426801 Encapsulated diagnostics and therapeutics in nanoparticles—conjugated to tropic cells and methods for their use	Patent 10426801 was granted and assigned to City of Hope on October, 2019 by the United States Patent and Trademark Office.	City of Hope	City of Hope	United States Patent and Trademark Office	10426801	October 1, 2019
‌ US Patent 7425415 Method for detecting methylated CpG islands	Patent 7425415 was granted and assigned to City of Hope on September, 2008 by the United States Patent and Trademark Office.		City of Hope	United States Patent and Trademark Office	7425415	September 16, 2008
‌ US Patent 9783825 Recombinant adeno-associated vectors for targeted treatment	Patent 9783825 was granted and assigned to City of Hope on October, 2017 by the United States Patent and Trademark Office.	City of Hope	City of Hope	United States Patent and Trademark Office	9783825	October 10, 2017

...

Results per page:

286 results

0 selected

286 results

0 selected